- Home
- PSQH vs FBIOP Comparison
PSQH vs FBIOP Comparison
Compare PSQH & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- FBIOP
- Stock Information
- Founded
- PSQH 2021
- FBIOP N/A
- Country
- PSQH United States
- FBIOP United States
- Employees
- PSQH N/A
- FBIOP 186
- Industry
- PSQH Advertising
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- PSQH Consumer Discretionary
- FBIOP Health Care
- Exchange
- PSQH Nasdaq
- FBIOP Nasdaq
- Market Cap
- PSQH N/A
- FBIOP N/A
- IPO Year
- PSQH N/A
- FBIOP N/A
- Fundamental
- Price
- PSQH $2.18
- FBIOP $5.75
- Analyst Decision
- PSQH Strong Buy
- FBIOP
- Analyst Count
- PSQH 2
- FBIOP 0
- Target Price
- PSQH $6.00
- FBIOP N/A
- AVG Volume (30 Days)
- PSQH 574.1K
- FBIOP N/A
- Earning Date
- PSQH 03-13-2025
- FBIOP N/A
- Dividend Yield
- PSQH N/A
- FBIOP N/A
- EPS Growth
- PSQH N/A
- FBIOP N/A
- EPS
- PSQH N/A
- FBIOP N/A
- Revenue
- PSQH $23,199,434.00
- FBIOP N/A
- Revenue This Year
- PSQH $73.40
- FBIOP N/A
- Revenue Next Year
- PSQH $71.26
- FBIOP N/A
- P/E Ratio
- PSQH N/A
- FBIOP N/A
- Revenue Growth
- PSQH 308.01
- FBIOP N/A
- 52 Week Low
- PSQH $2.00
- FBIOP N/A
- 52 Week High
- PSQH $7.77
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- PSQH 30.08
- FBIOP 35.47
- Support Level
- PSQH $2.58
- FBIOP $5.50
- Resistance Level
- PSQH $2.35
- FBIOP $6.74
- Average True Range (ATR)
- PSQH 0.18
- FBIOP 0.27
- MACD
- PSQH -0.01
- FBIOP -0.08
- Stochastic Oscillator
- PSQH 14.63
- FBIOP 20.00
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.